Ebola is one of the world’s biggest viral threat since the AIDS epidemic hit in the early 1980s, likely affecting over 25,000 people1.
However, the battle against Ebola is being won as more and more caretakers have been placed in regions of Africa such as Sierra Leone and Liberia to treat patients. One of the biggest complications associated with treating Ebola is fluid loss due to fever, diarrhea and vomiting. Methods of care have necessitated distributing fluids to patients to deliver antibiotics, antimaliarial treatments, as well as vitamin and mineral replacements. Just recently, Parthers in Health (PIH), an international healthcare organization, was deployed in Port Loko in Sierra Leone and placed what may be the first intraosseous line in the history of Ebola treatment and saved the life of an infant girl named Jariatu2. This marks a turning point and medical breakthrough for the future of Ebola treatment.
Since achieving an IV line isn’t always an option, the intraosseous route (through the bone marrow) offers an alternative solution to delivering fluids to Ebola patients. The story of Jariatu is one of hopefully many more survival stories to come and demonstrates the need for healthcare workers to have the right tools and strategies for caring for the victims of this life-threating disease. PerSys Medical offers the NIO, a safe, easy to use intraosseous infusion device that effectively facilitates the delivery of fluid and drugs to the bone marrow, as an alternative option when the intravenous route is inaccessible. Research has proven the NIO to be up to 98% effective with an extensive focus on consistent application and ease-of-use. PerSys Medical joins the fight in the battle against Ebola with the hope of saving more lives and tackling one of the world’s deadliest diseases.
For more information on the NIO, visit www.nio-pm.com
- World Health Organization: Ebola data and statistics
- Denver Post: Ebola battle is not over